InsidersTradesSigma
Total declarations
Company
▲ Purchases (15 ops.)
▼ Sales (7 ops.)
Insider track record
OtherDisclosed buys
15
Disclosed sells
7
T+90 hit rate
0%
T+90 mean return
-43.6%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Medytox Inc.. Insider active across 1 company, notably Evolus, Inc.. Aggregated, 22 disclosures have been recorded. Breakdown: 15 buys · 7 sells. Total volume traded: €38m. History available since 11 August 2021. The latest transaction was disclosed on 16 October 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Declarations22 total
1,690,663 shares@ US$7.5031.6% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-23-012379:0
2,187,511 shares@ US$8.5045.6% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-23-001621:0
23,000 shares@ US$10.99020.6% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-23-001468:0
Canonical exit: 10 Nov 2021 (T+90)
38,304 shares@ US$8.99170.9% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-22-010336:0
6,848 shares@ US$8.950.2% of flowCommon Stock, $0.00001 par value per shareSEC:0001839882-22-023112:0
73,000 shares@ US$10.26952.0% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-22-009830:0
15,300 shares@ US$10.39080.4% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-22-009717:0
26,000 shares@ US$13.28310.9% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-22-008344:0
51,000 shares@ US$10.93270.11% mcap7.0% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-009158:0
Canonical exit: 25 Nov 2021 (T+90)
51,000 shares@ US$10.93271.2% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-009158
Canonical exit: 25 Nov 2021 (T+90)
44,000 shares@ US$11.12240.096% mcap6.1% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-009024:0
Canonical exit: 23 Nov 2021 (T+90)
44,000 shares@ US$11.12241.1% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-009024
Canonical exit: 23 Nov 2021 (T+90)
69,781 shares@ US$11.03130.15% mcap9.7% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008933:0
Canonical exit: 21 Nov 2021 (T+90)
69,781 shares@ US$11.03131.7% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008933
Canonical exit: 21 Nov 2021 (T+90)
55,000 shares@ US$10.51110.11% mcap7.3% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008879:0
Canonical exit: 17 Nov 2021 (T+90)
55,000 shares@ US$10.51111.3% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008879
Canonical exit: 17 Nov 2021 (T+90)
70,000 shares@ US$10.68660.15% mcap9.4% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008746:0
Canonical exit: 15 Nov 2021 (T+90)
70,000 shares@ US$10.68661.7% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008746
Canonical exit: 15 Nov 2021 (T+90)
49,714 shares@ US$10.97711.2% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008661
Canonical exit: 11 Nov 2021 (T+90)
49,714 shares@ US$10.97710.11% mcap6.9% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008661:0
Canonical exit: 11 Nov 2021 (T+90)
26,160 shares@ US$10.76980.056% mcap3.5% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008519:0
Canonical exit: 9 Nov 2021 (T+90)
26,160 shares@ US$10.76980.6% of flowCommon Stock, $0.00001 par value per shareSEC:0001387131-21-008519
Canonical exit: 9 Nov 2021 (T+90)
22 of 22 declarations
About Medytox Inc.
Medytox Inc. is a director and insider at Evolus, Inc.
